17. Conclusion
reduced nerve damage, TBI
Our research found that implementing RIPC as a treatment method, specifically during craniotomy therapy for patients with severe TBI, resulted in enhanced outcomes at the 6-month mark, reduced nerve damage, and lowered both hospital expenses and length of stay. This finding provides evidence to support the execution of a substantial randomized clinical trial, incorporating a practical primary measure, for the implementation of RIPC therapy upon hospital admission for individuals in the early stage of TBI.